ENTRATA, INC.
No SEC Form 4 filings for $ENT in the last 30 days.
See all $ENT insider activity →Entain (ENT) stock fell 2.7% after adjusting its 2026 financial guidance due to Brazil's ban on online sports betting. The company now expects lower-end EBITDA and online margin, with online net gaming revenue growth reduced to 4-6% from 5-7%. Brazil was projected to contribute 5% of revenue. The FTSE 100 rose 0.26% amid U.S.-Iran diplomacy news.
Entrata (ENT) filed for a proposed IPO on the NYSE. Goldman Sachs, J.P. Morgan, and Barclays will serve as lead underwriters. The filing marks a step toward the company's public debut.
Sharecast reports FTSE 100 movers. Pharmaceutical and tobacco stocks fell, with GSK, AstraZeneca, BAT and Imperial Brands among the weakest. Gains included Experian, Sage Group and Relx, linked to a Reuters report on Silver Lake talks to buy Workday. IG Group rose after RBC reiterated ‘outperform’ and kept a 1,850p target, citing oversold shares post Underdog acquisition.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning ENT (ENTRATA, INC.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.
Recent ENT coverage spans market movers, regulation and ipo.
Guidance downgrade and regulatory shock create downside pressure on Entain stock.
Entrata (ENT) filed for a proposed IPO on the NYSE. Goldman Sachs, J.P. Morgan, and Barclays will serve as lead underwriters. The filing marks a step toward the company's public debut.
The article does not disclose a tradable, company-specific driver for Entain.
ENT’s interim print shows outperformance versus expectations, but the article provides no new guidance beyond the interim period.
Entain’s decline appears driven by general market pullback, not a new Entain catalyst.
AlphAI scores every news story that mentions ENT with an AI model for sentiment and relevance, and aggregates insider trades from ENTRATA, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Entain (ENT) stock fell 2.7% after adjusting its 2026 financial guidance due to Brazil's ban on online sports betting. The company now expects lower-end EBITDA and online margin, with online net gaming revenue growth reduced to 4-6% from 5-7%. Brazil was projected to contribute 5% of revenue. The FTSE 100 rose 0.26% amid U.S.-Iran diplomacy news.
2 min readEntrata (ENT) filed for a proposed IPO on the NYSE. Goldman Sachs, J.P. Morgan, and Barclays will serve as lead underwriters. The filing marks a step toward the company's public debut.
1 min readSharecast reports FTSE 100 movers. Pharmaceutical and tobacco stocks fell, with GSK, AstraZeneca, BAT and Imperial Brands among the weakest. Gains included Experian, Sage Group and Relx, linked to a Reuters report on Silver Lake talks to buy Workday. IG Group rose after RBC reiterated ‘outperform’ and kept a 1,850p target, citing oversold shares post Underdog acquisition.
3 min readThe article is a hotlist of UK-listed company updates. Ethtry PLC agreed heads of terms to buy 100% of Dunbar Energy for an indicative combined pre-money equity value of US$15m. Savills reported 6-month revenue up 9% and underlying PBT up 47%. Rank, Entain, NeoTerra, Distil, Ethernity, Bezant, and Oxford BioDynamics also issued trading, interim, or project updates.
7 min readLondon’s FTSE 100 was down about 26 points to ~10,627 as investors trimmed gains after a weaker US jobs report eased Federal Reserve rate-hike expectations. Gold rose ~1.5% to $4,183.92/oz. InterContinental Hotels Group, Tesco and Entain fell, while Fresnillo gained. Samsung helped lift Asian tech stocks after reports of an Anthropic custom AI chip.
4 min readEntain said it agreed to sell a 20% interest in Entain Holdings (CEE) Ltd to joint venture partner EMMA Capital in a phased exit. The deal values Entain CEE at about €2.1bn (c.10x EBITDA) and provides ~€425m cash, including €395m on completion plus an early-2027 payment. Net proceeds will reduce debt; completion is expected in Q4 2026.
6 min read
